+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
MIDSMAL400

Nifty MidSmallcap 400 Share Price

 

 

Nifty MidSmallcap 400 live price: ₹20740.45. It opened at ₹21,007 vs previous close ₹21,110; intraday high/low: ₹21,098/₹20,648. The 50 & 200 DMA stand at ₹20,488.84/₹19,897.11.

Nifty MidSmallcap 400 Performance

  • Today's Low
  • ₹20,648
  • Today's High
  • ₹21,098
  • 52 Week Low
  • ₹17,391
  • 52 Week High
  • ₹21,246
  • Open Price₹21,007
  • Previous Close₹21,110
  • Volume0
  • 50 DMA₹20,488.84
  • 100 DMA₹20,156.13
  • 200 DMA₹19,897.11

Nifty MidSmallcap 400 Chart

Investment Returns

  • Over 1 Month + 1.93%
  • Over 3 Month + 14.06%
  • Over 6 Month + 1.33%
  • Over 1 Year + 1.5%

Smart Investing Starts Here Start SIP with Nifty MidSmallcap 400 for Steady Growth!

Invest Now

Nifty MidSmallcap 400 Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 30.78
  • PEG Ratio
  • -
  • Market Cap Cr
  • -
  • P/B Ratio
  • -
  • Average True Range
  • 237.52
  • EPS
  • 0
  • Dividend Yield
  • 0.65
  • MACD Signal
  • 199.09
  • RSI
  • 49.39
  • MFI
  • -

Latest Stock News Updates

SAIL CMD Panda warns high taxes, royalty to make iron ore costlier

SAIL warns higher royalties and mining levies could raise iron ore costs, adding pressure on India's expanding steel industry amid decarbonisation challenges

Natco Pharma board approves nearly 2,500 cr investment in South Africa

Natco Pharma on Wednesday announced investments of nearly Rs 2,500 crore in South Africa, including infusing Rs 1,400 crore in its arm in the country with an aim to enter new geographies. The company will also increase its stake in South Africa-based Adcock Ingram Holdings Proprietary Ltd (Adcock Ingram) to 49 per cent from 35.75 per cent, with the "acquisition valued at Rs 1,069 crore at the prevailing exchange rate", NATCO Pharma said in a regulatory filing. The board of directors at its meeting held on Wednesday approved investing up to "Rs 1,400 crore in Natco Pharma South Africa Proprietary Ltd, a wholly-owned subsidiary", it added. As for increasing stake in Adcock Ingram, Natco said it will acquire 19,618,825 shares for ZAR 92.50 (Rs 5.89) per share, thus increasing its holding from 35.75 per cent to 49 per cent with a total investment cost of ZAR 1.8 billion (Rs 1,069 crore at the prevailing exchange rate), excluding certain associated transaction costs and other expenses.

Naukri Q1 strength fuels Info Edge rally, but sustaining momentum is key

Rally has found its wind, but sustained billings growth will keep it on course

Nifty MidSmallcap 400 Financials

Nifty MidSmallcap 400 Technicals

EMA & SMA

Current Price
₹20,740.45
-370 (-1.75%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹20,854.00
  • 50 Day
  • ₹20,488.80
  • 100 Day
  • ₹20,156.10
  • 200 Day
  • ₹19,897.10

Resistance and Support

20828.87 Pivot Speed
  • R3 21,460.63
  • R2 21,279.52
  • R1 21,009.98
  • S1 20,559.33
  • S2 20,378.22
  • S3 20,108.68

Nifty MidSmallcap 400 Shareholding Pattern

No data available.

Nifty MidSmallcap 400 FAQs

Nifty MidSmallcap 400 share price is ₹20,740 As on 09 July, 2026 | 04:15

The P/E ratio of Nifty MidSmallcap 400 is 30.78 As on 09 July, 2026 | 04:15

The PB ratio of Nifty MidSmallcap 400 is 4.31 As on 09 July, 2026 | 04:15

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23